{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:03:04Z","timestamp":1789596184468,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.tube.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,2,2]],"date-time":"2016-02-02T21:30:10Z","timestamp":1454448610000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study"],"prefix":"10.1016","volume":"98","author":[{"given":"J.","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.","family":"Bhoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Betai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.K.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.01.004_bib1","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2014"},{"key":"10.1016\/j.tube.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project","volume":"282","author":"Dye","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.tube.2016.01.004_bib3","series-title":"Drug susceptibility in the chemotherapy of mycobacterial infections","first-page":"13","article-title":"Antituberculosis drugs: pharmacokinetics","author":"Peloquin","year":"1991"},{"key":"10.1016\/j.tube.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/ajrccm\/148.3.650","article-title":"Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis","volume":"148","author":"Ellard","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2016.01.004_bib5","series-title":"Diagnosis and management of neurological disorders","first-page":"143","article-title":"Tuberculous meningitis","author":"Kalita","year":"2011"},{"key":"10.1016\/j.tube.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1086\/430616","article-title":"Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis","volume":"192","author":"Thwaites","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.tube.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/AAC.00064-11","article-title":"Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis","volume":"55","author":"Thwaites","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.01.004_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1378\/chest.124.4.1476","article-title":"Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong","volume":"124","author":"Yew","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.tube.2016.01.004_bib10","first-page":"851","article-title":"Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial","volume":"38","author":"Kalita","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tube.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified antituberculosis therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.tube.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/jnnp.68.3.300","article-title":"Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysis","volume":"68","author":"Misra","year":"2000","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.tube.2016.01.004_bib13","article-title":"Prospective analysis of 55 cases of tuberculosis meningitis (TBM) in North Indian","volume":"9","author":"Kaur","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"key":"10.1016\/j.tube.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.tube.2016.01.004_bib15","series-title":"Treatment of tuberculosis guidelines fourth edition","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.tube.2016.01.004_bib16","first-page":"146","article-title":"Predictors of drug induced hepatotoxicity in tuberculous meningitis","volume":"5","author":"Misra","year":"2014","journal-title":"J\u00a0Neuroinfect Dis"},{"key":"10.1016\/j.tube.2016.01.004_bib17","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Antituberculosis drug-induced hepatotoxicity","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2016.01.004_bib18","first-page":"979","article-title":"Effect of rifampicin and isoniazid on the steady state pharmacokinetics of moxifloxacin","volume":"136","author":"Ramachandran","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tube.2016.01.004_bib19","doi-asserted-by":"crossref","first-page":"e67030","DOI":"10.1371\/journal.pone.0067030","article-title":"Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients","volume":"8","author":"Jawahar","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.tube.2016.01.004_bib20","first-page":"704","article-title":"Intensive short course chemotherapy in the management of tuberculous meningitis","volume":"2","author":"Donald","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.tube.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-3476(89)80862-5","article-title":"Cerebrospinal fluid concentrations of ethionamide in children with tuberculous meningitis","volume":"115","author":"Donald","year":"1989","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.tube.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5692\/clinicalneurol.55.123","article-title":"A\u00a0case of tuberculous meningitis complicated with multiple drug hypersensitivity to antituberculosis agents","volume":"55","author":"Arai","year":"2015","journal-title":"Rinsho Shinkeigaku"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T15:56:27Z","timestamp":1537026987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":22,"alternative-id":["S1472979215302729"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.01.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}